Breeding a new Ganoderma lucidum strain with increased contents of individual ganoderic acids by mono-mono crossing of genetically modified monokaryons
- PMID: 38873146
- PMCID: PMC11169689
- DOI: 10.3389/fmicb.2024.1410368
Breeding a new Ganoderma lucidum strain with increased contents of individual ganoderic acids by mono-mono crossing of genetically modified monokaryons
Abstract
Ganoderic acids (GAs) are major functional components of Ganoderma lucidum. The study aimed to breed a new G. lucidum strain with increased contents of individual GAs. Two mating-compatible monokaryotic strains, G. 260125 and G. 260124, were successfully isolated from the dikaryotic G. lucidum CGMCC 5.0026 via protoplast formation and regeneration. The Vitreoscilla hemoglobin gene (vgb) and squalene synthase gene (sqs) were overexpressed in the monokaryotic G. 260124 and G. 260125 strain, respectively. Mating between the G. 260124 strain overexpressing vgb and the G. 260125 strain overexpressing sqs resulted in the formation of the new hybrid dikaryotic G. lucidum strain sqs-vgb. The maximum contents of ganoderic acid (GA)-T, GA-Me, and GA-P in the fruiting body of the mated sqs-vgb strain were 23.1, 15.3, and 39.8 μg/g dry weight (DW), respectively, 2.23-, 1.75-, and 2.69-fold greater than those in G. lucidum 5.0026. The squalene and lanosterol contents increased 2.35- and 1.75-fold, respectively, in the fruiting body of the mated sqs-vgb strain compared with those in the G. lucidum 5.0026. In addition, the maximum expression levels of the sqs and lanosterol synthase gene (ls) were increased 3.23- and 2.13-fold, respectively, in the mated sqs-vgb strain. In summary, we developed a new G. lucidum strain with higher contents of individual GAs in the fruiting body by integrating genetic engineering and mono-mono crossing.
Keywords: Ganoderma; breeding; ganoderic acids; genetic engineering; mono–mono crossing.
Copyright © 2024 Zhou, Kong, Huang, Li, Feng and Xu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Increased production of ganoderic acids by overexpression of homologous farnesyl diphosphate synthase and kinetic modeling of ganoderic acid production in Ganoderma lucidum.Microb Cell Fact. 2019 Jun 28;18(1):115. doi: 10.1186/s12934-019-1164-3. Microb Cell Fact. 2019. PMID: 31253150 Free PMC article.
-
Overexpression of the homologous lanosterol synthase gene in ganoderic acid biosynthesis in Ganoderma lingzhi.Phytochemistry. 2017 Feb;134:46-53. doi: 10.1016/j.phytochem.2016.11.006. Epub 2016 Nov 25. Phytochemistry. 2017. PMID: 27894599
-
Enhancement of ganoderic acid production by constitutively expressing Vitreoscilla hemoglobin gene in Ganoderma lucidum.J Biotechnol. 2016 Jun 10;227:35-40. doi: 10.1016/j.jbiotec.2016.04.017. Epub 2016 Apr 11. J Biotechnol. 2016. PMID: 27080449
-
Chemodiversity, pharmacological activity, and biosynthesis of specialized metabolites from medicinal model fungi Ganoderma lucidum.Chin Med. 2024 Mar 22;19(1):51. doi: 10.1186/s13020-024-00922-0. Chin Med. 2024. PMID: 38519991 Free PMC article. Review.
-
Strategies to Increase the Production of Triterpene Acids in Ligzhi or Reishi Medicinal Mushroom (Ganoderma lucidum, Agaricomycetes): A Review.Int J Med Mushrooms. 2024;26(5):25-41. doi: 10.1615/IntJMedMushrooms.2024052871. Int J Med Mushrooms. 2024. PMID: 38780421 Review.
Cited by
-
Unlocking the Potential of Ganoderma lucidum (Curtis): Botanical Overview, Therapeutic Applications, and Nanotechnological Advances.Pharmaceutics. 2025 Mar 26;17(4):422. doi: 10.3390/pharmaceutics17040422. Pharmaceutics. 2025. PMID: 40284417 Free PMC article. Review.
-
ATP deficiency triggers ganoderic acids accumulation via fatty acid β-oxidation pathway in Ganoderma lucidum.Microb Cell Fact. 2025 Mar 11;24(1):62. doi: 10.1186/s12934-025-02668-2. Microb Cell Fact. 2025. PMID: 40069729 Free PMC article.
References
-
- Adaskaveg J. E., Gilbertson R. L. (1986). Cultural studies and genetics of sexuality of Ganoderma lucidum and G. tsugae in relation to the taxonomy of the G. lucidum complex. Mycologia. 78, 694–705.
-
- Ahmad M. F., Wahab S., Ahmad F. A., Ashraf S. A., Abullais S. S., Saad H. H. (2022). Ganoderma lucidum: a potential pleiotropic approach of ganoderic acids in health reinforcement and factors influencing their production. Fungal Biol. Rev. 39, 100–125. doi: 10.1016/j.fbr.2021.12.003 - DOI
-
- Avin F. A., Bhassu S., Rameeh V., Tan Y. S., Vikineswary S. (2016). Genetics and hybrid breeding of Pleurotus pulmonarius: heterosis, heritability and combining ability. Euphytica 209, 85–102. doi: 10.1007/s10681-016-1638-x - DOI
-
- Feng N., Zhang J., Yue Y., Yang M., Wang C., Zhou S., et al. . (2023). “Triterpene compound extracted from Ganoderma lucidum mycelia and application in preparation of anti-inflammatory drug (in Chinese)” in China Patent, CN115894591, 2023.0404. Beijing, China: Intellectual Property Publishing House Co., Ltd.
LinkOut - more resources
Full Text Sources
Miscellaneous
